Quality Policy System
Transparency
Organisational structure
Contact points
About us
Links
F.A.Q.
Events
Contact
Sightless version
RSS
Sitemap
Magyar
News
Supervision
Inspection
GMP Inspections
GLP Inspections
GCP Inspections
GDP Inspections
Pharmacovigilance Inspection
Pharmacovigilance
Definitions
How could adverse effects be recognized?
Spontaneous report of adverse effects
PSUR
Clinical report of adverse effects
Eudravigilance
Pharmacovigilance requirements
Counterfeit medicines
Advertisement control
Methodology
Pharmaceutical methodology
NIP medicine reviewers
Pharmacopoeia Hungarica VIII
Formulae Normales VII
Drug information
Drug database
Lists
Paramedicines
Expiry date extension
Temporary discontinuation of sale
Rapid Alert
Withdrawal from the market
Laws and regulations
Finance
Forms
Hits
new application: 1 - 10, of 10 hits
1. Centralized Procedure
2. MRP-CMS-New application flow chart
3. MRP-RMS-New application flow chart
4. National Marketing Authorisation – New Application flow chart
5. National procedure
6. Notice to the MAH or person/company authorized for communication on behalf of MAH regarding declaration on pack sizes of medicinal products pending under MR or DC procedure
7. Notice to the MAH or person/company authorized for communication on behalf of MAH regarding declaration on pack sizes of medicinal products pending under MR or DC procedure
8. Validation criterions for new application
9. Validation criterions for new application
10. Validation criterions of new application
« back
printer version
National Institute of Pharmacy
| H-1051 Budapest, Zrínyi u. 3. | Mail: 1372 P.O. Box: 450.
Tel: +36 1 88 69 -300 | Fax: +36 1 88 69-460 |
Contact
|
Impressum
|
Copyright
Opening hours for docketing: Monday to Thursday: 8.30-12.00, Friday: 8.30-11.00
